Research in brief: Empagliflozin for patients with heart failure and preserved ejection fraction

Clin Med (Lond). 2022 Jan;22(1):75-76. doi: 10.7861/clinmed.rib.22.1.1.

Authors

Rajan S Pooni¹, Tevfik F Ismail²

Affiliations

¹ St Bartholomew's Hospital, London, UK.
² King's College London, London, UK and consultant cardiologist, Guy's and St Thomas' NHS Foundation Trust, London, UK.

No abstract available

Keywords: empagliflozin; heart failure; preserved ejection fraction.

Publication types

Comment

MeSH terms

Benzhydryl Compounds / therapeutic use
Glucosides* / therapeutic use
Heart Failure* / drug therapy
Humans
Stroke Volume

Substances

Benzhydryl Compounds
Glucosides
empagliflozin